ALERT

Schedule your COVID-19 vaccination now! We are unable to accommodate walk-ins. Please do not call St. Luke's clinics directly about COVID vaccine scheduling. Unless you need to call for an emergency, please use myChart for questions and appointments. To ensure we're able to provide safe care in a safe environment for all patients, masks are required in all St. Luke's facilities, regardless of COVID-19 vaccination status. Learn more.

toggle mobile menu Menu
toggle search menu

Site Navigation

Supplemental

Menu

National Study for Kids with Nearsightedness

St. Luke's Children's Ophthalmology participates in national study.

Now enrolling children ages 5 to 12 with myopia (nearsightedness) for a national study. 

St. Luke’s Children’s Ophthalmology is part of a national study regarding an eye drop called low-dose atropine that has been shown to slow nearsightedness in children by 50%. The study is funded by the National Institutes of Health and is run by a national group of pediatric eye doctors. 

We're currently enrolling children ages 5 to 12 with nearsightedness. Children will use low dose atropine, or an eye drop with no medicine in it, every day for two years. The study will measure changes in nearsightedness while taking the drop, and after it has been stopped. 

Please call (208) 381-6912 with questions or for more information on enrolling your child.



Principle Investigator

Katherine Lee, MD

Articles & Resources

  • showing 1 of 1